| Trial ID: | L0545 |
| Source ID: | NCT00369538
|
| Associated Drug: |
Losartan, Hydrochlorothiazide
|
| Title: |
Specific Blockage of Angiotensine 2 and Podocyturia in Glomerular Nephropathies With Hypertension and Proteinuria
|
| Acronym: |
|
| Status: |
SUSPENDED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Proteinuria|Hypertension|End Stage Renal Disease
|
| Interventions: |
DRUG: losartan, hydrochlorothiazide|DRUG: hydrochlorothiazide, losartan
|
| Outcome Measures: |
Primary: Podocyturia | Secondary: Proteinuria;|selectivity index of proteinuria|arterial blood pressure
|
| Sponsor/Collaborators: |
Sponsor: University Hospital, Strasbourg, France
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
20
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-08
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2009-02-18
|
| Locations: |
Service de Néphrologie, Hôpital Civil, Hôpitaux Universitaires, Strasbourg, 67091, France
|
| URL: |
https://clinicaltrials.gov/show/NCT00369538
|
